BICE

Serial Number 98960444
688

Registration Progress

Application Filed
Jan 14, 2025
Under Examination
Sep 30, 2025
Approved for Publication
Aug 5, 2025
Published for Opposition
Aug 5, 2025
Registered

Trademark Image

BICE

Basic Information

Serial Number
98960444
Filing Date
January 14, 2025
Published for Opposition
August 5, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Sep 30, 2025
Application
Pending
Classes
001 042

Rights Holder

Commit Biologics ApS

99
Address
Universitetsbyen 81
Aarhus 8000AarhusC
DK

Ownership History

Commit Biologics ApS

Original Applicant
99
Aarhus DK

Commit Biologics ApS

Owner at Publication
99
Aarhus DK

Legal Representation

Attorney
Eric T. Fingerhut

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

8 events
Date Code Type Description Documents
Sep 30, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 5, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 5, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 30, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 25, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 23, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 12, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 14, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Chemical, biochemical, biological and biotechnical preparations, namely, antibodies, bi- and multispecific antibodies and fragments thereof, in the nature of monoclonal antibodies, their derivatives or conjugates for in vivo or in vitro scientific and industrial research and development related to diseases; active chemical ingredients for use in the manufacture of pharmaceutical preparations for treating cancer, infectious diseases, and autoimmune diseases
Class 042
Medical and biological research, in particular research into antibodies and bi- and multispecific antibodies or fragments, including monoclonal antibodies, their derivatives or conjugates, and the development of pharmaceutical products based on antibodies and bi- and multispecific antibodies or fragments, including monoclonal antibodies, their derivatives or conjugates; Chemical analysis

Classification

International Classes
001 042